- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06605183
10,000 Step Club: Community Walking Program for People with Parkinson's Disease ((10KSC))
10,000 STEP CLUB: Community Walking Program to Decrease Sedentary Behavior, Fear of Falling Avoidance Behavior, Loneliness, and Social Isolation in Parkinson's Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The 10,000 Step Club (10KSC) is a 6-month community walking program conducted at various local parks in Las Vegas (LV), Nevada for people with Parkinson's disease (PD). There will be three walking groups and each group will meet at a local park once weekly for a 60-minute walk. These walking groups will be led by UNLV physical therapy students who will organize, coordinate, and manage the different walking groups. Participants will be encouraged to attend at least one walking group per week in their area but will be permitted to participate at the other walking groups on different days if they desire to get in a second or third walk that week. Participants in the program will use Nordic walking poles to promote stability and upright posture, and to encourage full body movement and arm use.
There will be three different walking groups throughout Las Vegas in areas with few PD exercise programs and higher proportions of people with Parkinson's disease in lower socioeconomic regions and historically underserved areas. The 10KSC program will be offered in both English and Spanish. Participants will be given a step watch to wear over the 6 months of the program and will be encouraged to build up their physical activity to eventually average 10,000 steps per day. The watches will be used to track step counts in real-time and there will be an incentive program to motivate participants and recognize achievements related to program goals. The program is designed to get people with Parkinson's disease out of their homes, cultivate a culture of connection with others with Parkinson's disease to decrease social isolation and loneliness, and to be collectively accountable for a common goal toward more physical activity. The 10KSC will be evaluated for effectiveness, feasibility, and safety. The program will target recruitment of 60 participants with Parkinson's disease. Participation will be free of charge and care partners will be encouraged to participate as well. The program inclusion criteria will be "pragmatic" which means that there will be few exclusion criteria and the only inclusion criterion will be a diagnosis of Parkinson's disease by a neurologist.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Merrill R Landers, DPT, PhD
- Phone Number: 702-895-1377
- Email: merrill.landers@unlv.edu
Study Locations
-
-
Nevada
-
Las Vegas, Nevada, United States, 89154
- Recruiting
- Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV
-
Contact:
- Merrill R Landers, DPT, PhD
- Phone Number: 702-895-1377
- Email: merrill.landers@unlv.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 30-85 years old
- Neurologist-diagnosed Parkinson's disease
- Able to walk independently with or without a walking aid (e.g., cane, walker)
- Willing to participate in a 6-month study
Exclusion Criteria:
- Health diagnosis that would limit exercise participation (e.g., heart problems, uncontrolled blood pressure, exercise-induced asthma).
- Dementia. This will be determined by completing the Montreal Cognitive Assessment
- Participants with poor walking ability (determined using the Timed Up and Go Test during initial testing).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: One hour per week of community walking for 6 months
Participants will participate in one, 60-minute group walk using Nordic poles at a local community park.
Participants will be assessed before and after the 6-month program.
|
This is a group, community walking program at local parks using Nordic walking poles.
Participants will be encouraged to walk briskly but safely for 60 minutes one time per week with the ultimate goal of using this community walking program to build up their step count to 10,000 steps per day.
We do not anticipate that the weekly walk will get them to 10,000 steps but we will use that as a weekly event to drive behavioral change throughout the week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily step count average
Time Frame: From enrollment to the end of the 6-month community walking program.
|
Daily step count average over one week as determined using a step watch and using real-time data acquisition software.
|
From enrollment to the end of the 6-month community walking program.
|
|
Fear of Falling Avoidance Behavior
Time Frame: From enrollment to the end of the 6-month community walking program.
|
This will be assessed using the modified Fear of Falling Avoidance Behavior Questionnaire which is a self-report scale ranging from 0 to 56 with higher scores suggestive of more fear of falling avoidance behavior.
|
From enrollment to the end of the 6-month community walking program.
|
|
Social isolation
Time Frame: From enrollment to the end of the 6-month community walking program.
|
Patient-Reported Outcomes Measurement Information System (PROMIS) v2.0 - Social Isolation - Short Form 8a.
This is a self-report questionnaire ranging from 8 to 40 with higher scores suggestive of more social isolation.
|
From enrollment to the end of the 6-month community walking program.
|
|
Loneliness
Time Frame: From enrollment to the end of the 6-month community walking program.
|
Patient-Reported Outcomes Measurement Information System (PROMIS) v2.0 - Loneliness - Fixed Form.
This is a self-report questionnaire with scores ranging from 5 to 25 with higher scores suggestive of more loneliness.
|
From enrollment to the end of the 6-month community walking program.
|
|
Self-efficacy
Time Frame: From enrollment to the end of the 6-month community walking program.
|
Patient-Reported Outcomes Measurement Information System (PROMIS) v1.0 - Self-Efficacy for Chronic Conditions - Managing Emotions - Short Form 8a.
This is a self-report questionnaire with scores ranging from 8 to 40 with higher scores suggestive of more self-efficacy.
|
From enrollment to the end of the 6-month community walking program.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program goals - feasibility
Time Frame: Through the completion of the study, an average of 6-months.
|
Number of participants that started and completed the 6-month program (75% of enrollees will complete the full, 6-month program). Percent week-to-week attendance of the schedule walking days (75% of the participants will have attended at least 75% of the weekly walks (one required per week)). Percent of participants who wear the step watch more than 20 hours per day (75% of the participants will be compliant with wearing the step watch for at least 20 hours per day). Percentage of participants who felt the program was beneficial and worthwhile. (75% of the participants who completed the program will agree or strongly agree that the program was beneficial and worthwhile). |
Through the completion of the study, an average of 6-months.
|
|
Program goals - safety
Time Frame: Through the completion of the study, an average of 6-months.
|
Number of falls and other injuries sustained during the weekly walks.
|
Through the completion of the study, an average of 6-months.
|
|
Enrollment goals - diversity
Time Frame: Through the completion of the study, an average of 6-months.
|
Participation of Black/African American PwP. 1. Recruitment will be deemed a success if at least 8 participants who identify as Black/African American are recruited and retained. This number is based on the percent of people in LV who identify as Black/African American (12.9%). Participation of Hispanic/Latino/Latina PwP. 1. Recruitment will be deemed a success if at least 20 participants who identify as Hispanic/Latino/Latina are recruited and retained. This number is based on the percent of people in LV who identify as Hispanic/Latino/Latina (33.3%). |
Through the completion of the study, an average of 6-months.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UNLVPT 10KSC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Community walking program using Nordic walking poles
-
East Tennessee State UniversityRecruitingPARKINSON DISEASE (Disorder)United States
-
Pacific Northwest University of Health SciencesTerminatedParkinson DiseaseUnited States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)CompletedPeripheral Arterial DiseaseUnited States
-
Consorci Hospitalari de VicCompleted
-
Raquel SebioFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauCompleted
-
Federal University of Rio Grande do SulHospital de Clinicas de Porto Alegre; Federal University of Health Science...CompletedParkinson Disease | Parkinson Disease 10Brazil
-
St. Louis UniversityRecruitingParkinson Disease | Parkinson Disease, IdiopathicUnited States
-
Cairo UniversityCompletedCerebral PalsyEgypt
-
Azienda Ospedaliera Universitaria Integrata VeronaUniversita di VeronaUnknownHypertension | Metabolic Syndrome | Overweight and Obesity | Cardiovascular Risk Factor | Sarcopenic Obesity | Disability Physical | Abdominal ObesityItaly
-
Federal University of Rio Grande do SulCompleted